Pages Menu
Categories Menu

Posted by on May 4, 2010 in Cardiology, Oncology, Pharma, Rheumatology

The Best-Seller Dance

The Best-Seller Dance

By using newly released data from Thomson Reuters (for 2010 and 2014) and EvaluatePharma (for 2016), a timeline graphic of the 7 drugs that are expected to remain within the top 10 best sellers is presented. Notably only 1 of the 7, Crestor, is a conventional pill.


Best_sellers.pngAdvair (fluticasone/salmeterol; GSK) and Remicade (infliximab; Centocor Ortho Biotech) lose position, while the other drugs are expected to rise on the list. The future top seller, depending on your source, is Humira (adalimumab; Abbott) or Avastin (bevacizumab; Roche).

bmartin (1127 Posts)

A native East Tennessean, Barbara Martin is a formerly practicing, board-certified neurologist who received her BS (psychology, summa cum laude) and MD from Duke University before completing her postgraduate training (internship, residency, fellowship) at the Hospital of the University of Pennsylvania in Philadelphia. She has worked in academia, private practice, medical publishing, drug market research, and continuing medical education (CME). For the last 3 years, she has worked in a freelance capacity as a medical writer, analyst, and consultant. Follow Dr. Barbara Martin on and Twitter.